Escape from the matrix: Multiple mechanisms for fibroblast activation in pulmonary fibrosis

Proceedings of the American Thoracic Society

Volumn 5, Issue 3, 2008, Pages 311-315

  Laurent, Geoffrey J ^a   McAnulty, Robin J ^a   Hill, Michael ^a   Chambers, Rachel ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Fibroblasts; Lung fibrosis; Matrix

Indexed keywords

ANGIOTENSIN; CYTOKINE; ENDOTHELIN; VASOCONSTRICTOR AGENT;

APOPTOSIS; CELL ACTIVATION; CELL FUNCTION; CONFERENCE PAPER; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; LUNG FIBROSIS; MOLECULAR MECHANICS; PATHOGENESIS; PHENOTYPE; PLASTICITY; TISSUE INJURY;

ANGIOTENSINS; APOPTOSIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOKINES; DINOPROSTONE; ENDOTHELINS; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; PEPTIDE HYDROLASES; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; WOUND HEALING;

EID: 42049111233     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200710-159DR     Document Type: Conference Paper

References (71)

1. McAnulty RJ, Laurent GJ. Fibroblasts. In: Barnes P, Drazen J, Rennard S, Thomson N, editors. Asthma and COPD: basic mechanisms and clinical management. London: Academic Press; 2002. pp. 139-144.
2. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J 2007;30:134-155.
3. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007;176:277-284.
4. Thannickal VJ, Toews GB, White ES, Lynch JP, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395-417.
5. Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987;252:C1-C9.
6. Dunsmore SE, Chambers RC, Laurent GJ. Matrix proteins. In: Gibson GJ, Geddes DM, Costabel U, Sterk PJ, Corrin B, editors. Respiratory medicine, 3rd ed. Oxford (UK): Saunders; 2003. pp. 82-92.
7. McAnulty RJ. Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol 2007;39:666-671.
8. McAnulty RJ, Campa JS, Cambrey AD, Laurent GJ. The effect of transforming growth factor β on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta 1991;1091:231-235.
9. Lindahl GE, Chambers RC, Papakrivopoulou J, Dawson SJ, Jacobsen MC, Bishop JE, Laurent GJ. Activation of fibroblast procollagen α 1(I) transcription by mechanical strain is transforming growth factor-β- dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J Biol Chem 2002;277:6153-6161.
10. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-β1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 2003;162:533-546.
11. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 2000;97:1778-1783.
12. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002;99:6292-6297.
13. Coker RK, Laurent GJ. Anti-cytokine approaches in pulmonary fibrosis: bringing factors into focus. Thorax 1997;52:294-296.
14. Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 1998;11:1218-1221.
15. Howell JE, McAnulty RJ. TGF-β: its role in asthma and therapeutic potential. Curr Drug Targets 2006;7:547-565.
16. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ. Transforming growth factors-β1, -β2, and -β3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997;150:981-991.
17. Shull MM, Ormsby I, Kier AB, Pawlowsky S, Diebold RJ, Yin M, Allen R, Sidman C, Preotzel G, Calvin D, et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
18. McAnulty RJ. In: Polosa R, Holgate ST, editors. Therapeutic strategies asthma, modern therapeutic targets. Oxford, UK: Clinical Publishing; 2007. pp. 15-32.
19. Coker RK, Laurent GJ. Pathogenesis of pulmonary fibrosis: implications for pharmacological intervention. In: Walters EH, du Bois RM, editors. Immunology and interstitial lung disease. London: Chapman & Hall; 1995. pp. 19-36.
20. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000;161:1999-2004.
21. Peacock A, Dawes KE, Shock A, Gray AJ, Reeves JT, Laurent GJ. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 1992;7:492-499.
22. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-650.
23. Marshall R, Bellingan GJ, Laurent GJ. The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax 1998;53:815-817.
24. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-1269.
25. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr. A placebo-controlled trial of interferon gamma-1β in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-133.
26. McAnulty RJ, Chambers RC, Laurent GJ. Regulation of fibroblast procollagen production: transforming growth factor-β1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J 1995;307:63-68.
27. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-β isoforms on fibroblast cell cultures. Biochem J 1997;321:639-643.
28. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995;4:1861-1868.
29. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriquez NA, Booth H, Laurent GJ, Hart SL, Foster ML, McAnulty RJ. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001;58:1411-1422.
30. Hodges RJ, Jenkins RG, Wheeler-Jones CP, Copeman DM, Bottoms SE, Bellingan GJ, Nanthakumar CB, Laurent GJ, Hart SL, Foster ML, et al. Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol 2004;165:1663-1676.
31. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002;22:1631-1636.
32. Hill MR, Papafili A, Booth H, Lawson P, Hubner M, Beynon H, Read C, Lindahl G, Marshall RP, McAnulty RJ, et al. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006;174:915-922.
33. Jenkins RG, Herrick SE, Meng QH, Kinnon C, Laurent GJ, McAnulty RJ, Hart SL. An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Ther 2000;7:393-400.
34. Moraes TJ, Chow CW, Downey GP. Proteases and lung injury. Crit Care Med 2003;31(4 Suppl):S189-S194.
35. Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, Kagawa J, Takizawa T. Administration of a1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am J Respir Crit Care Med 1992;145:651-656.
36. Mitsuhashi H, Asano S, Nonaka T, Hamamura I, Masuda K-I, Kiyoki M. Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am J Respir Crit Care Med 1996;153:369-374.
37. Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 1997;156:260-265.
38. Chua F, Dunsmore SE, Clingen PH, Mutsaers SE, Shapiro SD, Segal AW, Roes J, Laurent GJ. Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol 2007;170:65-74.
39. Chambers RC, Dabbagh K, McAnulty RJ, Gray AJ, Blanc-Brude O, Laurent GJ. Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J 1998;333:121-127.
40. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 2000;275:35584-35591.
41. Dabbagh K, Chambers RC, Laurent GJ. From clot to collagen: coagulation peptides in interstitial lung disease. Eur Respir J 1998;11:1002-1005.
42. Ruf W, Riewald M. Science review: role of coagulation protease cascades in sepsis. Crit Care 2003;7:123-129.
43. Blanc-Brude OP, Archer F, Leoni P, Derian C, Bolsover S, Laurent GJ, Chambers RC. Factor Xa stimulates fibroblast procollagen production, proliferation and calcium signaling via PAR1 activation. Exp Cell Res 2005;304:16-27.
44. Howell DCJ, Goldsack NR, Marshall RP, Starke R, Purdy G, Laurent GJ, Chambers RC. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 2001;159:1383-1395.
45. Howell DC, Johns RH, Lasky JA, Shan B, Scotton CJ, Laurent GJ, Chambers RC. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 2005;166:1353-1365.
46. Jenkins RG, Su X, Su G, Scotton C, Camerer E, Laurent GJ, David G, Chambers R, Matthay M, Sheppard D. Ligation of protease-activated receptor 1 enhances α(v) β6 integrin-dependent TGF-β activation and promotes acute lung injury. J Clin Invest 2006;116:1606-1614.
47. Laurent GJ, Millward DJ. Protein turnover during skeletal muscle hypertrophy. Fed Proc 1980;39:42-47.
48. Eckes B, Krieg T. Regulation of connective tissue homeostasis in the skin by mechanical forces. Clin Exp Rheumatol 2004;22(3, Suppl 33):S73-S76.
49. Bishop JE, Butt RP, Laurent GJ. The role of mechanical force in the regulation of fibroblast function: implications for enhanced collagen deposition during pulmonary vascular remodelling. European Respiratory Review 1993;3:613-617.
50. Tschumperlin DJ, Drazen JM. Chronic effects of mechanical force on airways. Annu Rev Physiol 2006;68:563-583.
51. Torday JS, Rehan VK. Mechanotransduction determines the structure and function of lung and bone: a theoretical model for the pathophysiology of chronic disease. Cell Biochem Biophys 2003;37:235-246.
52. Sarasa-Renedo A, Chiquet M. Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand J Med Sci Sports 2005;15:223-230.
53. Tamada M, Sheetz MP, Sawada Y. Activation of a signaling cascade by cytoskeleton stretch. Dev Cell 2004;7:709-718.
54. Henson PM. Possible roles for apoptosis and apoptotic cell recognition in inflammation and fibrosis. Am J Respir Cell Mol Biol 2003;29(3, Suppl):S70-S76.
55. Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 2003;29:490-498.
56. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998;275:L1192-L1199.
57. Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006;3:350-356.
58. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999;104:13-19.
59. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000;279:L143-L151.
60. Lee CG, Kang HR, Homer RJ, Chupp G, Elias JA. Transgenic modeling of transforming growth factor-β1: role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc 2006;3:418-423.
61. Holgate ST, Lackie PM, Howarth PH, Roche WR, Puddicombe SM, Richter A, Wilson SJ, Holloway JW, Davies DE. Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. Int Arch Allergy Immunol 2001;124:253-258.
62. Gauldie J, Kolb M, Sime PJ. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res 2002;3:1.
63. Selman M, King TE Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151.
64. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-13185.
65. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
66. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et al. The integrin αvβ6 binds and activates latent TGF β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328.
67. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.
68. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007;353:104-108.
69. Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006;35:175-181.
70. Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 2007;30:835-839.
71. Das AM, Griswold DE, Molloy CJ, Protter AA, Laurent GJ. Fighting pulmonary fibrosis: new science brings new therapeutic opportunities. Drug Discov Today 2004;1:361-368.